This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Is AnheuserBusch InBev (BUD) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Here is how Anheuser-Busch Inbev (BUD) and Lamb Weston (LW) have performed compared to their sector so far this year.
BUD or DEO: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
BUD vs. DEO: Which Stock Is the Better Value Option?
Diageo (DEO) 1H FY23 Earnings & Sales Rise on Strong Demand
by Zacks Equity Research
Diageo's (DEO) first-half fiscal 2023 results reflect gains from its strong premium portfolio, growth across all regions and favorable industry trends, which aid sales and the organic operating margin.
Procter & Gamble (PG) Beats Q2 Earnings & Sales Estimates
by Zacks Equity Research
Procter & Gamble (PG) Q2 results reflect gains from robust pricing and a favorable mix, mostly offset by elevated commodity and input costs, and currency headwinds.
The Zacks Analyst Blog Highlights Nike, Novartis, Wells Fargo, Broadcom and Anheuser-Busch
by Zacks Equity Research
Nike, Novartis, Wells Fargo, Broadcom and Anheuser-Busch are part of the Zacks top Analyst Blog.
Why is Molson Coors (TAP) an Attractive Option for the Long Run?
by Zacks Equity Research
Molson Coors (TAP) looks poised for growth on the back of its innovation and premiumization efforts, revitalization plan, and improved pricing.
Top Stock Reports for NIKE, Novartis & Wells Fargo
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including NIKE, Inc. (NKE), Novartis AG (NVS) and Wells Fargo & Company (WFC).
Best Momentum Stocks to Buy for January 17th
by Zacks Equity Research
RYAM, BUD and KALA made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 17, 2022.
BUD or DEO: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
BUD vs. DEO: Which Stock Is the Better Value Option?
Are Consumer Staples Stocks Lagging AnheuserBusch InBev (BUD) This Year?
by Zacks Equity Research
Here is how Anheuser-Busch Inbev (BUD) and Ingredion (INGR) have performed compared to their sector so far this year.
Here's Why Anheuser-Busch Inbev (BUD) is a Strong Value Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Investors Need to Take Advantage of These 2 Consumer Staples Stocks Now
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Here's Why AB InBev (BUD) Continues to Outpace Its Industry
by Zacks Equity Research
AB InBev (BUD) is poised for growth on the business momentum, premiumization, investment in its brands and accelerated digital transformation amid cost headwinds.
Early Q4 Earnings Results and Analyst Reports for Merck, Bristol-Myers & Deere
by Sheraz Mian
Today's Research Daily features update on the Q4 earnings season and new research reports on Merck (MRK), Bristol-Myers (BMY) and Deere (DE).
Molson Coors (TAP) Up 11.7% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Molson Coors (TAP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Will FEMSA's (FMX) Digital Strategy Aid Growth Amid Cost Woes?
by Zacks Equity Research
FEMSA (FMX) looks good on continued growth in the digital business as well as strength across all segments. The expansion strategy of its national distribution platform is on track.
4 Stocks to Watch Despite the Hardships in the Alcohol Industry
by Zacks Equity Research
The Beverages - Alcohol industry is likely to stay strong on its premiumization, pricing and e-commerce growth efforts despite the headwinds related to elevated input, freight and packaging costs. Players like DEO, BUD, STZ and BF.B will likely capitalize.
AB InBev (BUD) Tops Q3 Earnings Estimates, Raises EBITDA View
by Zacks Equity Research
AB InBev's (BUD) Q3 results benefit from the continued business momentum, owing to relentless execution, investment in its brands and accelerated digital transformation.
Things You Need to Know Before FEMSA's (FMX) Q3 Earnings
by Zacks Equity Research
FEMSA's (FMX) Q3 results are expected to reflect gains from strength across businesses, owing to effective growth strategies and robust demand across markets, amid supply-chain and inflation woes.
Things You Need to Know Before Newell's (NWL) Q3 Earnings
by Zacks Equity Research
Inflationary pressure and fewer retail orders are likely to have hurt Newell's (NWL) Q3 performance. Online strength, strong demand and core sales growth are likely to have aided.
Things to Decide the Fate of AB InBev (BUD) in Q3 Earnings
by Zacks Equity Research
Relentless execution, investment in its brands and accelerated digital transformation are likely to aid AB InBev (BUD) in Q3 amid adverse currency rates, cost inflation and supply-chain cost hike.
High Demand & Solid Pricing to Aid PepsiCo's (PEP) Q3 Earnings
by Zacks Equity Research
PepsiCo's (PEP) Q3 results are expected to reflect gains from the momentum in its beverage and convenient food units. Market share gains, innovation and robust pricing are likely to have been drivers.
Business Momentum & Diversification to Support FEMSA (FMX)
by Zacks Equity Research
FEMSA (FMX) looks poised for growth on its diversified business portfolio, growth in digital business and expansion in the specialized distribution business.
How Constellation Brands (STZ) is Placed Ahead of Q2 Earnings
by Zacks Equity Research
Constellation Brands' (STZ) Q2 results to reflect continued gains from strong demand for its premium portfolio and strength in the beer business amid rising costs and supply-chain challenges.
Digital Investments & Premiumization to Aid AB InBev (BUD)
by Zacks Equity Research
AB InBev (BUD) looks well-poised based on a strong brand portfolio and investments in operation excellence. Higher cost of sales and SG&A expenses remain headwinds.